Featured Research

from universities, journals, and other organizations

Drug-related morbidity in more than 10 percent of adults, Swedish study finds

Date:
April 22, 2014
Source:
University of Gothenburg
Summary:
Twelve percent of adults in Sweden have diseases related to their use of medicines. But in four cases of ten it would have been possible to avoid the undesired effects, research shows. Two effects were most commonly reported: side effects, and insufficient effect of the drug. "The studies show that both those treating outpatients and those treating inpatients must become better at recognizing drug-related morbidity. Further, new studies should be carried out by scientists, experts in safety and healthcare personnel together to develop preventative strategies," says the researcher.

Twelve percent of adults in Sweden have diseases related to their use of medicines. But in four cases of ten it would have been possible to avoid the undesired effects. These are the conclusions of a thesis presented at the Sahlgrenska Academy.

Katja Hakkarainen and her research colleagues have used 7,099 questionnaires and 4,970 patient medical records in ึsterg๖tland to map drug-related morbidity. Their work has included side effects, toxicity, the development of drug dependence, the insufficient effect of drugs, and lack of drug treatment.

The study is described in Katja Hakkarainen's thesis, and shows that 19% of all adults in Sweden report some form of drug-related morbidity, while examination of the medical records gives a figure of 12%.

Two effects were most commonly reported: side effects, and insufficient effect of the drug.

Could have been prevented At the same time, 20% of those who completed the questionnaire stated that they themselves, healthcare personnel or relatives could have prevented these effects.

Clinical experts who have examined the drug-related morbidity described in the medical records also came to the conclusion that 39%, or four cases of ten, could have been prevented.

"Our results show that drug-related morbidity is a significant public health problem, and that it must be prevented across the whole of the healthcare sector," says Katja Hakkarainen, pharmacist and researcher at the Sahlgrenska Academy, University of Gothenburg.

Broader spectrum Most previous studies in the field have focused on side effects associated with drug use. Katja Hakkarainen's thesis, in contrast, draws attention to a broader spectrum of drug-related morbidity, including insufficient effects of medicines. The latter effect means, for example, that a potentially active drug has been taken at the wrong dose by the patient, or that it has been prescribed or used wrongly in some other way.

"The studies show that both those treating outpatients and those treating inpatients must become better at recognizing drug-related morbidity. Further, new studies should be carried out by scientists, experts in safety and healthcare personnel together to develop preventative strategies," says Katja Hakkarainen.

The questionnaire study was carried out in 2010, and the medical records were reviewed for year 2008 , in collaboration with the Nordic School of Public Health NHV and Link๖ping University.

The thesis Prevalence and nature of adverse drug events and the potential for their prevention -- Population-based studies among adults was successfully defended at a disputation on 21 March, 2014.

Link to the thesis: http://hdl.handle.net/2077/34825


Story Source:

The above story is based on materials provided by University of Gothenburg. Note: Materials may be edited for content and length.


Cite This Page:

University of Gothenburg. "Drug-related morbidity in more than 10 percent of adults, Swedish study finds." ScienceDaily. ScienceDaily, 22 April 2014. <www.sciencedaily.com/releases/2014/04/140422095921.htm>.
University of Gothenburg. (2014, April 22). Drug-related morbidity in more than 10 percent of adults, Swedish study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/04/140422095921.htm
University of Gothenburg. "Drug-related morbidity in more than 10 percent of adults, Swedish study finds." ScienceDaily. www.sciencedaily.com/releases/2014/04/140422095921.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins